Abstract:Paclitaxel (TaxolTM), an alkaloid of diterpenoid family, is one of the most widely used anti-cancer drugs due to its effectiveness against a variety of tumors. Rather than directly extraction and chemical synthesis of paclitaxel or its intermediates from yew plants, construction of a microbial cell factory for paclitaxel biosynthesis will be more efficient and sustainable. The challenge for biosynthesis of paclitaxel lies on the insufficient precursor, such as taxadien-5α-ol. In this study, we report a recombinant Escherichia coli strain constructed with a heterologous mevalonate pathway, a taxadiene synthase from yew, and a cytochrome P450-mediated oxygenation system for the de novo production of taxadien-5α-ol, the first product of the multi-step taxadiene oxygenation metabolism The key enzymes including taxadiene synthases and cytochrome P450 reductases were screened, and the linker for fusing taxadiene-5α-hydroxylase with its reductase partner cytochrome P450 reductase was optimized. By reducing the metabolic burden and optimizing the fermentation conditions, the final production of total oxygenated taxanes was raised up to 27 mg L −1 in a 50-mL flask cultivation, of which the yield of taxadien-5α-ol was 7.0 mg L −1 , representing approximately a 12-fold and 23-fold improvements, respectively, as compared with the initial titers. The engineered MVA pathway for the overproduction of terpenoid precursors can serve as an efficient platform for the production of other valuable terpenoids.

An asymmetric catalytic multi-component reaction enabled the green synthesis of isoserine derivatives and semi-synthesis of paclitaxel

Synthesis of Paclitaxel Side Chain Via Multi-Component Reaction and Its Application to the Synthesis of Paclitaxel Analogues

Asymmetric Total Synthesis of Taxol

Total Synthesis of Paclitaxel.

Regioselective Protection of 10-Deacetylbaccatin III and Semi-Synthesis of Paclitaxel

A Convenient One-Pot Approach to Paclitaxel (taxol) Side Chain Via 1,3-Dipolar Cycloaddition of Carbonyl Ylides and N -Benzoylbenzyl Imines

Research Advances in Clinical Applications, Anticancer Mechanism, Total Chemical Synthesis, Semi-Synthesis and Biosynthesis of Paclitaxel

Synthesis of Taxol and Docetaxel by Using 10‐Deacetyl‐7‐xylosyltaxanes

Biosynthesis of paclitaxel using synthetic biology

Uncovering the Baccatin III Biosynthetic Pathway for Sustainable Taxoid Supply

Post-genomic illumination of paclitaxel biosynthesis

A general strategy for the synthesis of taxane diterpenes

[Advances in paclitaxel biosynthesis and transcriptional regulation mechanisms]

Biochemical synthesis of taxanes from mevalonate

Construction of an Escherichia coli cell factory to synthesize taxadien-5α-ol, the key precursor of anti-cancer drug paclitaxel

Technological Improvement of the Semisynthesis of Taxol

Synthesis of 7,9-Dideoxybaccatin Iv Analogs from Sinenxan A

Characterization and heterologous reconstitution of Taxus biosynthetic enzymes leading to baccatin III

Total Synthesis of Taxol Enabled by Intermolecular Radical Coupling and Pd-Catalyzed Cyclization

A Novel Method to Synthesize Docetaxel and Its Isomer with High Yields

A Strategy to Synthesize Taxol Side Chain and (-)-epi Cytoxazone Via Chiral Bronsted Acid-Rh-2(Oac)(4) Co-Catalyzed Enantioselective Three-Component Reactions